Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands. 28 May Dr D Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. CB2 receptor-mediated migration of immune cells: it can go either way.